| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6140943 | Virology | 2013 | 7 Pages |
Abstract
RAVs were predominantly observed at R155, A156, and/or D168 during virologic failure on vaniprevir/P/R. Double/triple RAVs were identified in patients remaining viremic on triple therapy, suggesting evolution of resistance under selective pressure.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Richard J.O. Barnard, Carolyn M. McHale, William Newhard, Carol A. Cheney, Donald J. Graham, Amy L. Himmelberger, Julie Strizki, Peggy M.T. Hwang, Amber A. Rivera, Jacqueline D. Reeves, David Nickle, Mark J. DiNubile, Daria J. Hazuda, Niloufar Mobashery,